SCHEMBL30001979

SCHEMBL30001979

CN[C@@H](CO[Si](C)(C)C(C)(C)C)c1cc([N+](=O)[O-])ccn1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 4/20 0.34
ADRB1 P08588 4/20 0.34
ADRB3 P13945 4/20 0.34
EGFR P00533 2/20 0.32
IGF1R P08069 2/20 0.32
CYP2C19 P33261 1/20 0.32
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 3/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CFTR P13569 1/20 0.31
ACHE P22303 1/20 0.31
SLC6A4 P31645 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
KDM4E B2RXH2 1/20 0.31
PKM P14618 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CRHBP P24387 1/20 0.31
CRHR2 Q13324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30001392 0.82 ADRB2 (0.34) ADRB2ADRB1ADRB3EGFRIGF1R
SCHEMBL29186968 0.75 CYP2C19 (0.34) ADRB2ADRB1ADRB3EGFRIGF1R
SCHEMBL30001896 0.75 CYP2C19 (0.34) ADRB2ADRB1ADRB3EGFRIGF1R
SCHEMBL30001349 0.75 AURKA (0.37) ADRB2ADRB1ADRB3MAPTALDH1A1
SCHEMBL14831769 0.68 ALDH1A1 (0.44) ADRB2ADRB1ADRB3CYP2C19POLB
SCHEMBL3716664 0.68 TSHR (0.42) POLBGAAMAPTMEN1KMT2A
SCHEMBL1439430 0.67
SCHEMBL10276744 0.67
SCHEMBL31407212 0.67 CYP3A4 (0.42) ADRB2ADRB1ADRB3CYP2C19MEN1
SCHEMBL30001220 0.67 CYP2D6 (0.41) EGFRIGF1RCYP2C19GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347032-A1 SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2024-04-10 EP disclosed
WO-2022256702-A1 SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-12-08 WO disclosed